iRhythm Technologies, Inc. (IRTC)

NASDAQ: IRTC · IEX Real-Time Price · USD
133.00
-6.04 (-4.34%)
May 16, 2022 4:00 PM EDT - Market closed
Market Cap3.96B
Revenue (ttm)340.89M
Net Income (ttm)-124.19M
Shares Out29.79M
EPS (ttm)-3.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume234,409
Open139.33
Previous Close139.04
Day's Range132.23 - 142.15
52-Week Range41.66 - 169.54
Beta1.12
AnalystsBuy
Price Target178.37 (+34.1%)
Earnings DateMay 5, 2022

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and E...

IndustryHealth Care Equipment & Supplies
IPO DateOct 20, 2016
CEOKevin King
Employees1,157
Stock ExchangeNASDAQ
Ticker SymbolIRTC
Full Company Profile

Financial Performance

In 2021, IRTC's revenue was $322.83 million, an increase of 21.74% compared to the previous year's $265.17 million. Losses were -$101.36 million, 131.3% more than in 2020.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is 178.37, which is an increase of 34.11% from the latest price.

Price Target
$178.37
(34.11% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why iRhythm Technologies jumped 20%

iRhythm Technologies Inc. (NASDAQ: IRTC) was up 20% after the digital healthcare solutions firm focusing on cardiac care advancement announced its financial results for the quarter ending March 31, 2022...

1 week ago - Invezz

Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today

iRhythm Technologies won a pair of lucrative reimbursement codes from Medicare, leading IRTC stock to rocket early Friday. The post Why Highly Rated iRhythm Technologies Is Making A 20% Jump Today appea...

1 week ago - Investors Business Daily

Investors Cheer Revised, Better Than Expected iRhythm's FY22 Outlook

iRhythm Technologies Inc (NASDAQ: IRTC) posted Q1 sales of $92.4 million, up 24.3% Y/Y, beating the consensus of $86.76 million. The developer of remote external electrocardiogram monitors reported an a...

1 week ago - Benzinga

IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 24.53% and 5.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

IRhythm Technologies (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

iRhythm Technologies to Report First Quarter 2022 Financial Results on May 5, 2022

SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced t...

3 weeks ago - GlobeNewsWire

Missed Intuitive Surgical? Buy This Stock Instead

Much as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.

3 weeks ago - The Motley Fool

Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

SAN FRANCISCO, April 03, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announces the resul...

1 month ago - GlobeNewsWire

iRhythm Technologies Announces Amendment to Term Loan Agreement

Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 Provides enhanced credit facility up to $100 million with favorable terms and facil...

1 month ago - GlobeNewsWire

iRhythm Technologies (IRTC) Soars 4.3%: Is Further Upside Left in the Stock?

iRhythm Technologies (IRTC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the nea...

1 month ago - Zacks Investment Research

iRhythm® Technologies Announces Kevin King to Retire from Board of Directors

SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today ...

2 months ago - GlobeNewsWire

iRhythm Technologies (IRTC) Upgraded to Buy: What Does It Mean for the Stock?

iRhythm Technologies (IRTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 months ago - Zacks Investment Research

Zio® by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter...

Additional clinical research shows bradyarrhythmias can be detected with 14-day cardiac monitoring through Zio XT before and after TAVR Additional clinical research shows bradyarrhythmias can be detecte...

2 months ago - GlobeNewsWire

IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 9.84% and 4.61%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results

SAN FRANCISCO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported fina...

2 months ago - GlobeNewsWire

iRhythm Technologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

SAN FRANCISCO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced th...

3 months ago - GlobeNewsWire

Will IRhythm Technologies Stock Continue To See Higher Levels After A 20% Rally In A Month?

The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and cardiac monitoring products, has seen a rise of 20% over the last one month (twenty-one tradi...

3 months ago - Forbes

Strength Seen in iRhythm Technologies (IRTC): Can Its 27.6% Jump Turn into More Strength?

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d...

4 months ago - Zacks Investment Research

iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on ​​the r...

4 months ago - GlobeNewsWire

IRTC Stock: 17 Things to Know About iRhythm as Shares Rocket Higher Today

Irhythm Technologies (IRTC) stock is rising higher Monday alongside heavy trading of the shares and we know what's behind that movement! The post IRTC Stock: 17 Things to Know About iRhythm as Shares Ro...

4 months ago - InvestorPlace

iRhythm® Technologies to Present at the 40th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the...

4 months ago - GlobeNewsWire

IRhythm Stock Falls On Lowered Sales Guidance

Wearable electrocardiograph patch maker IRhythm Technologies Inc's (NASDAQ: IRTC) lowered its revenue guidance for 2021 due to unforeseen impacts related to the COVID-19 Delta variant, customer staffing...

6 months ago - Benzinga

IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates

iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 25.69% and 2.27%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Why iRhythm Technologies Stock Skyrocketed Today

Investors think that new Medicare payment guidelines will benefit the company.

6 months ago - The Motley Fool

Why Are iRhythm Shares Soaring Today?

iRhythm Technologies Inc (NASDAQ: IRTC) commented on the CMS (Centers for Medicare and Medicaid Services) Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule. In the Final Rule, CMS did...

6 months ago - Benzinga